Cargando…
A single-cell map of antisense oligonucleotide activity in the brain
Antisense oligonucleotides (ASOs) dosed into cerebrospinal fluid (CSF) distribute broadly throughout the central nervous system (CNS). By modulating RNA, they hold the promise of targeting root molecular causes of disease and hold potential to treat myriad CNS disorders. Realization of this potentia...
Autores principales: | Mortberg, Meredith A, Gentile, Juliana E, Nadaf, Naeem M, Vanderburg, Charles, Simmons, Sean, Dubinsky, Dan, Slamin, Adam, Maldonado, Salome, Petersen, Caroline L, Jones, Nichole, Kordasiewicz, Holly B, Zhao, Hien T, Vallabh, Sonia M, Minikel, Eric Vallabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415122/ https://www.ncbi.nlm.nih.gov/pubmed/37188501 http://dx.doi.org/10.1093/nar/gkad371 |
Ejemplares similares
-
A single-cell map of antisense oligonucleotide activity in the brain
por: Mortberg, Meredith A, et al.
Publicado: (2023) -
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
por: Minikel, Eric Vallabh, et al.
Publicado: (2020) -
Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS
por: Kandasamy, Pachamuthu, et al.
Publicado: (2022) -
Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
por: Sinha, Rahul, et al.
Publicado: (2018) -
Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse
por: Depreux, Frederic F., et al.
Publicado: (2016)